These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 35931862)

  • 1. Mapping the cancer cell states conserved across solid tumors.
    Roden D; Swarbrick A
    Nat Genet; 2022 Aug; 54(8):1066-1067. PubMed ID: 35931862
    [No Abstract]   [Full Text] [Related]  

  • 2. Methodologic advances in the cytogenetic analysis of human solid tumors.
    Trent J; Crickard K; Gibas Z; Goodacre A; Pathak S; Sandberg AA; Thompson F; Whang-Peng J; Wolman S
    Cancer Genet Cytogenet; 1986 Jan; 19(1-2):57-66. PubMed ID: 3940180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-infiltrating dendritic cell states are conserved across solid human cancers.
    Gerhard GM; Bill R; Messemaker M; Klein AM; Pittet MJ
    J Exp Med; 2021 Jan; 218(1):. PubMed ID: 33601412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric solid tumor genomics and developmental pliancy.
    Chen X; Pappo A; Dyer MA
    Oncogene; 2015 Oct; 34(41):5207-15. PubMed ID: 25639868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atlas of clinically distinct cell states and ecosystems across human solid tumors.
    Luca BA; Steen CB; Matusiak M; Azizi A; Varma S; Zhu C; Przybyl J; Espín-Pérez A; Diehn M; Alizadeh AA; van de Rijn M; Gentles AJ; Newman AM
    Cell; 2021 Oct; 184(21):5482-5496.e28. PubMed ID: 34597583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic alterations in solid tumors. Introduction.
    Imreh S
    Semin Cancer Biol; 1999 Aug; 9(4):241-4. PubMed ID: 10448111
    [No Abstract]   [Full Text] [Related]  

  • 7. A Serial Analysis of Gene Expression (SAGE) database analysis of chemosensitivity: comparing solid tumors with cell lines and comparing solid tumors from different tissue origins.
    Stein WD; Litman T; Fojo T; Bates SE
    Cancer Res; 2004 Apr; 64(8):2805-16. PubMed ID: 15087397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights into the core Hippo signaling and biological macromolecules interactions in the biology of solid tumors.
    Mohammadi S; Arefnezhad R; Danaii S; Yousefi M
    Biofactors; 2020 Jul; 46(4):514-530. PubMed ID: 32445262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reconstruction of geno-phenotypic evolutionary sequences from intracellular patterns of molecular abnormalities in human solid tumors.
    Shackney SE; Smith CA; Pollice AA; Silverman JF
    Methods Mol Med; 2003; 75():431-49. PubMed ID: 12407758
    [No Abstract]   [Full Text] [Related]  

  • 10. Circular RNAs in Cancer.
    Lux S; Bullinger L
    Adv Exp Med Biol; 2018; 1087():215-230. PubMed ID: 30259369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pitfalls and promise of liquid biopsies for diagnosing and treating solid tumors in children: a review.
    Van Paemel R; Vlug R; De Preter K; Van Roy N; Speleman F; Willems L; Lammens T; Laureys G; Schleiermacher G; Tytgat GAM; Astrahantseff K; Deubzer H; De Wilde B
    Eur J Pediatr; 2020 Feb; 179(2):191-202. PubMed ID: 31897843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic role of cyclin B1 in solid tumors: a meta-analysis.
    Ye C; Wang J; Wu P; Li X; Chai Y
    Oncotarget; 2017 Jan; 8(2):2224-2232. PubMed ID: 27903976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of miR-142 in solid tumors: a meta-analysis.
    Liu R; Zheng S; Yu K; Yu Y; Yu C; Shi W; Ge Q; Ye Z; Shao Y
    Biosci Rep; 2021 Feb; 41(2):. PubMed ID: 33600577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Landscape of RAS Variations in 17,993 Pan-cancer Patients Identified by Next-generation Sequencing.
    Zhou S; Zhang D; Li J; Zhao J; Wang G; Zhang Y; Bai Y; Chen D; Wu H
    Pathol Oncol Res; 2020 Oct; 26(4):2835-2837. PubMed ID: 32602003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating developmental states of tumors and normal tissues using a linear time-ordered model.
    Zhang B; Chen B; Wu T; Xuan Z; Zhu X; Chen R
    BMC Bioinformatics; 2011 Feb; 12():53. PubMed ID: 21310084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of MUC16 Mutation With Response to Immune Checkpoint Inhibitors in Solid Tumors.
    Zhang L; Han X; Shi Y
    JAMA Netw Open; 2020 Aug; 3(8):e2013201. PubMed ID: 32845327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A molecular signature of metastasis in primary solid tumors.
    Ramaswamy S; Ross KN; Lander ES; Golub TR
    Nat Genet; 2003 Jan; 33(1):49-54. PubMed ID: 12469122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfer learning between preclinical models and human tumors identifies a conserved NK cell activation signature in anti-CTLA-4 responsive tumors.
    Davis-Marcisak EF; Fitzgerald AA; Kessler MD; Danilova L; Jaffee EM; Zaidi N; Weiner LM; Fertig EJ
    Genome Med; 2021 Aug; 13(1):129. PubMed ID: 34376232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment Patterns of Real-World Patients with TRK Fusion Cancer Treated by US Community Oncologists.
    Klink AJ; Kavati A; Gassama A; Kozlek T; Gajra A; Antoine R
    Target Oncol; 2022 Sep; 17(5):549-561. PubMed ID: 36089643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response Rates to Anti-PD-1 Immunotherapy in Microsatellite-Stable Solid Tumors With 10 or More Mutations per Megabase.
    Valero C; Lee M; Hoen D; Zehir A; Berger MF; Seshan VE; Chan TA; Morris LGT
    JAMA Oncol; 2021 May; 7(5):739-743. PubMed ID: 33599686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.